Inspyr Therapeutics Strengthens Clinical Development Capabilities with Appointment of Michael Elliott as Vice President of Clinical Operations WESTLAKE VILLAGE, Calif., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...